Product
mRNA-1283.211
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 2A, Randomized, Stratified, Observer-Blind Study to Evaluate the Immunogenicity and Safety of mRNA-1283 Vaccine Boosters for SARS-CoV-2Status: Completed, Estimated PCD: 2023-03-23